MANSC1 Antibody(C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H8J5 |
---|---|
Clone Names | 100416140 |
Other Names | MANSC domain-containing protein 1, Loss of heterozygosity 12 chromosomal region 3 protein, MANSC1, LOH12CR3 |
---|---|
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MANSC1 |
---|---|
Synonyms | LOH12CR3 |
Cellular Location | Membrane; Single-pass type I membrane protein |
Tissue Location | Widely expressed.. EMBL; AY358563; AAQ88926.1; -; mRNA EMBL; AK001160; BAA91526.1; -; mRNA EMBL; AK023622; BAB14621.1; -; mRNA EMBL; AC007621; -; NOT_ANNOTATED_CDS; Genomic_DNA EMBL; CH471094; EAW96254.1; -; Genomic_DNA EMBL; BC032998; AAH32998.1; -; mRNA CCDS; CCDS86284.1; -. [Q9H8J5-2] CCDS; CCDS8648.1; -. [Q9H8J5-1] RefSeq; NP_060520.2; NM_018050.2. [Q9H8J5-1] RefSeq; XP_016875020.1; XM_017019531.1 BioGRID; 120101; 99 IntAct; Q9H8J5; 90 STRING; 9606.ENSP00000438205; - GlyGen; Q9H8J5; 7 sites, 1 O-linked glycan (1 site) iPTMnet; Q9H8J5; - PhosphoSitePlus; Q9H8J5; - BioMuta; MANSC1; - DMDM; 48428493; - EPD; Q9H8J5; - jPOST; Q9H8J5; - MassIVE; Q9H8J5; - MaxQB; Q9H8J5; - PaxDb; Q9H8J5; - PeptideAtlas; Q9H8J5; - PRIDE; Q9H8J5; - ProteomicsDB; 81214; -. [Q9H8J5-1] Antibodypedia; 2339; 112 antibodies DNASU; 54682; - Ensembl; ENST00000396349; ENSP00000379638; ENSG00000111261. [Q9H8J5-2] Ensembl; ENST00000535902; ENSP00000438205; ENSG00000111261. [Q9H8J5-1] Ensembl; ENST00000626912; ENSP00000487244; ENSG00000281818. [Q9H8J5-2] Ensembl; ENST00000629245; ENSP00000487587; ENSG00000281818. [Q9H8J5-1] GeneID; 54682; - KEGG; hsa:54682; - UCSC; uc001rai.2; human. [Q9H8J5-1] CTD; 54682; - DisGeNET; 54682; - EuPathDB; HostDB:ENSG00000111261.13; - GeneCards; MANSC1; - HGNC; HGNC:25505; MANSC1 HPA; ENSG00000111261; Low tissue specificity neXtProt; NX_Q9H8J5; - OpenTargets; ENSG00000111261; - PharmGKB; PA134948173; - eggNOG; ENOG502RZBP; Eukaryota GeneTree; ENSGT00940000153377; - HOGENOM; CLU_054219_0_0_1; - InParanoid; Q9H8J5; - OMA; SQNCPTK; - OrthoDB; 778983at2759; - PhylomeDB; Q9H8J5; - TreeFam; TF336966; - PathwayCommons; Q9H8J5; - BioGRID-ORCS; 54682; 3 hits in 871 CRISPR screens ChiTaRS; MANSC1; human GenomeRNAi; 54682; - Pharos; Q9H8J5; Tdark PRO; PR:Q9H8J5; - Proteomes; UP000005640; Chromosome 12 RNAct; Q9H8J5; protein Bgee; ENSG00000111261; Expressed in saliva-secreting gland and 234 other tissues ExpressionAtlas; Q9H8J5; baseline and differential Genevisible; Q9H8J5; HS GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW InterPro; IPR013980; MANSC_dom InterPro; IPR011106; MANSC_N Pfam; PF07502; MANEC; 1 SMART; SM00765; MANEC; 1 PROSITE; PS50986; MANSC; 1 1: Evidence at protein level; Alternative splicing; Glycoprotein; Membrane; Polymorphism; Reference proteome; Signal; Transmembrane; Transmembrane helix SIGNAL 1..26 /evidence="ECO:0000255" CHAIN 27..431 /note="MANSC domain-containing protein 1" /id="PRO_0000021636" TOPO_DOM 27..385 /note="Extracellular" /evidence="ECO:0000255" TRANSMEM 386..408 /note="Helical" /evidence="ECO:0000255" TOPO_DOM 409..431 /note="Cytoplasmic" /evidence="ECO:0000255" DOMAIN 33..117 /note="MANSC" /evidence="ECO:0000255|PROSITE-ProRule:PRU00341" COMPBIAS 237..332 /note="Thr-rich" CARBOHYD 72 /note="N-linked (GlcNAc...) asparagine" /evidence="ECO:0000255" CARBOHYD 222 /note="N-linked (GlcNAc...) asparagine" /evidence="ECO:0000255" CARBOHYD 251 /note="N-linked (GlcNAc...) asparagine" /evidence="ECO:0000255" CARBOHYD 327 /note="N-linked (GlcNAc...) asparagine" /evidence="ECO:0000255" CARBOHYD 352 /note="N-linked (GlcNAc...) asparagine" /evidence="ECO:0000255" VAR_SEQ 14..47 /note="Missing (in isoform 2)" /evidence="ECO:0000303|PubMed:14702039" /id="VSP_055927" VARIANT 55 /note="V -> I (in dbSNP:rs3741798)" /evidence="ECO:0000269|PubMed:15489334" /id="VAR_021840" VARIANT 141 /note="L -> V (in dbSNP:rs34668262)" /id="VAR_061682" VARIANT 165 /note="D -> N (in dbSNP:rs17375215)" /id="VAR_051151" VARIANT 375 /note="N -> Y (in dbSNP:rs3741803)" /id="VAR_021841" SEQUENCE 431 AA; 46810 MW; 189136416F0F89AE CRC64; MFFGGEGSLT YTLVIICFLT LRLSASQNCL KKSLEDVVID IQSSLSKGIR GNEPVYTSTQ EDCINSCCST KNISGDKACN LMIFDTRKTA RQPNCYLFFC PNEEACPLKP AKGLMSYRII TDFPSLTRNL PSQELPQEDS LLHGQFSQAV TPLAHHHTDY SKPTDISWRD TLSQKFGSSD HLEKLFKMDE ASAQLLAYKE KGHSQSSQFS SDQEIAHLLP ENVSALPATV AVASPHTTSA TPKPATLLPT NASVTPSGTS QPQLATTAPP VTTVTSQPPT TLISTVFTRA AATLQAMATT AVLTTTFQAP TDSKGSLETI PFTEISNLTL NTGNVYNPTA LSMSNVESST MNKTASWEGR EASPGSSSQG SVPENQYGLP FEKWLLIGSL LFGVLFLVIG LVLLGRILSE SLRRKRYSRL DYLINGIYVD I |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Contains 1 MANSC domain.
References
Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.